HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
By Jessica Roe2025-11-18T09:55:00
Key points:
- Regulation (EU) 2024/1701 entered into force on 1 January 2025; revised classification guidelines apply from 15 January 2026
- Procedural changes include annual Type IA updates, super-grouping and mandatory worksharing
- Classification guidelines introduce risk-based downgrading, greater alignment between chemical and biological products, and new regulatory tools such as post-approval change management protocol (PACMP) and pharmaceutical product lifecycle management (PLCM)
To read more key points and the session summary, login as a member or register for free using the links below.